コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 2D T1-weighted imaging + PDFS imaging vs 3D T1-weighted imaging).
2 omputed based on the intensity values of the T1-weighted image.
3 hyperintense (n=12) and isointense (n=6) on T1-weighted images.
4 N), and pons (P) were measured on unenhanced T1-weighted images.
5 atheroma volume were measured on unenhanced T1-weighted images.
6 when contrast enhancement became apparent on T1-weighted images.
7 me-of-flight, and contrast material-enhanced T1-weighted images.
8 mages and were predominantly hyperintense on T1-weighted images.
9 k of contrast material uptake on posttherapy T1-weighted images.
10 weighted, and spoiled gradient-recalled-echo T1-weighted images.
11 be monitored with STIR and contrast-enhanced T1-weighted images.
12 enhancement of vessels with slow flow as do T1-weighted images.
13 of three-dimensional gradient-echo T2*- and T1-weighted images.
14 rom the hard palate to the vocal cords using T1-weighted images.
15 s showed homogeneous low signal intensity on T1-weighted images.
16 Edema was measured on T1-weighted images.
17 tter and brain stem, a hypointense region on T1-weighted images.
18 eighted, MR images but not on the unenhanced T1-weighted images.
19 were derived from SPM8 segmentations of the T1-weighted images.
20 geneous contrast enhancement on postcontrast T1-weighted images.
21 ompared with conventional segmentation of CE T1-weighted images.
22 lized nonenhanced T1-weighted images from CE T1-weighted images.
23 hand, it is hypointense and less evident in T1-weighted images.
24 rounded by areas of high signal intensity on T1-weighted images.
25 Cast appeared hyperintense on nonenhanced T1-weighted images.
26 n protein density-weighted fat-suppressed or T1-weighted images.
27 was manually segmented on three-dimensional T1-weighted images.
28 uded acquisition of DW and contrast-enhanced T1-weighted images.
29 hted, and dynamic contrast material-enhanced T1-weighted imaging.
30 tumors showed increased signal intensity at T1-weighted imaging.
31 ium-enhanced three-dimensional gradient-echo T1-weighted imaging.
32 olvement was evaluated semiquantitatively on T1-weighted images according to a visual score, and the
33 ignal intensity enhancement was evaluated on T1-weighted images acquired after the tissue cooled, and
37 ray matter (GM) volumes on three-dimensional T1-weighted images and changes in normal-appearing white
39 4.7 (standard deviation) to 5.19 +/- 6.3 on T1-weighted images and decreased from 14.73 +/- 7.4 to 0
40 had low to intermediate signal intensity on T1-weighted images and high signal intensity on T2-weigh
41 and subcutan masses as mainly hypointense on T1-weighted images and hyperintense on T2-weighted image
42 IRE ablation zones that were hypointense on T1-weighted images and hyperintense on T2-weighted image
43 ealed a mass including hyperintense areas on T1-weighted images and hypointense on fat-suppressed T1-
44 eously enhancing, and hypo- to isointense on T1-weighted images and iso- to slightly hyperintense on
48 iso- or hypointense relative to the liver on T1-weighted images and slightly hyperintense on T2-weigh
49 , the lesion signal intensity on precontrast T1-weighted images and the enhancement after repeat inje
50 h proton density-weighted fat-suppressed and T1-weighted images and were evaluated by two radiologist
51 were hypointense compared with the liver on T1-weighted images and were hyperintense on T2-weighted
52 xtacortical abnormalities with low signal on T1-weighted images and with very high signal on T2 FS se
54 hted, fluid-sensitive, and contrast-enhanced T1-weighted imaging) and functional (DCE MR imaging, DW
55 y images, fatty degeneration was assessed on T1-weighted images, and muscular fat fraction was quanti
56 e contralateral side (cNT)--in post-contrast T1-weighted images, and normalized the concentrations of
57 trast perfusion MR imaging and registered to T1-weighted images, and the fraction of enhancing mass w
58 usion-tensor imaging, three-dimensional (3D) T1-weighted imaging, and functional MR imaging at rest a
59 s can be visualized and monitored by T2- and T1-weighted imaging, and MRI lesion size agrees well wit
61 es and can be seen on transverse nonenhanced T1-weighted images as a fine line curving around the pos
62 2D T1-weighted imaging + PDFS imaging vs 3D T1-weighted imaging), as was sensitivity (per-lesion ana
63 ld also look at the bile ducts on unenhanced T1-weighted images, as biliary cast might be more easily
65 s: 1) A brain template derived from in-vivo, T1-weighted imaging at 1 mm isotropic resolution at 3 Te
68 nce, cine, and T2-weighted images as well as T1-weighted images before and after injection of gadobut
69 nversion time inversion-recovery [STIR], and T1-weighted imaging before and after intravenous adminis
70 vived to have an MRI scan; this showed, with T1 weighted images, bilateral symmetrically increased si
71 ducted a quantitative analysis of unenhanced T1-weighted images by using region of interest measureme
73 compared and combined with contrast-enhanced T1-weighted imaging (CET1WI), using liver explant as the
79 agnetic resonance imaging scanner to acquire T1-weighted images, diffusion tensor imaging datasets, a
80 ind that marmosets have significantly larger T1-weighted image enhancements in regions of the brain c
81 ion with isointense or hypointense signal on T1-weighted images, fluid-equivalent signal intensity on
82 e performed a region of interest analysis of T1-weighted images focusing on the sensorimotor cortex c
85 per is based upon high-resolution structural T1-weighted images from 82 current or past AAS users exc
87 DN to pons and GP to thalamus on unenhanced T1-weighted images from the last and first examinations
88 , they also remained hypointense to liver on T1-weighted images (from -4.87 +/- 6.1 to -1.79 +/- 5.7)
89 metastases remained hypointense to liver on T1-weighted images (from -5.77 +/- 5.9 to -7.8 +/- 6.8)
90 ng fat and cortical bone signal intensity at T1-weighted imaging (grade 1, 0%; grade 2, 3%; grade 3,
91 overy and gadolinium-enhanced fat-suppressed T1-weighted images had the highest sensitivity, and T1-w
92 ghted and gadolinium-enhanced fat-suppressed T1-weighted images had the highest specificity and least
95 ometry and voxel-based cortical thickness of T1-weighted images in 10 subjects with cervical spinal c
96 y of the lesions was isointense to muscle on T1-weighted images in all six patients and iso- to hyper
97 ton-density-weighted images were superior to T1-weighted images in depiction of the intraarticular di
99 ringlike patterns, could also be observed on T1-weighted images in patients with progressive MS, enab
100 ne defects with sharp margins observed using T1-weighted imaging in 2 planes, with a cortical break s
101 risk for metastases underwent whole-body 3D T1-weighted imaging in addition to the routine MR imagin
102 The threshold temperature of enhancement at T1-weighted imaging in normal liver was 53 degrees -57 d
103 eighted images, variable signal intensity on T1-weighted images, intense arterial phase enhancement a
104 iethylene triamine pentaacetic acid-enhanced T1-weighted imaging (inversion-recovery gradient echo pu
105 ates that an SI increase in the DN and GP on T1-weighted images is caused by serial application of th
106 cellent for MR cholangiopancreatography plus T1-weighted images (kappa for readers 1 and 2 = 0.806, k
107 arrier break down and hypointense lesions on T1-weighted images, magnetization transfer, T2 decay-cur
108 imaging, tumors were hypointense to liver on T1-weighted images (n = 11) and hyperintense to liver on
109 2D T1-weighted imaging + PDFS imaging vs 3D T1-weighted imaging; observer 2: P < .001 for 2D T1-weig
110 2D T1-weighted imaging + PDFS imaging vs 3D T1-weighted imaging; observer 2: P = .006 for 2D T1-weig
111 d images and three-dimensional gradient-echo T1-weighted images obtained before and after intravenous
113 ter proton signal enhancement is observed in T1-weighted images of the healthy mouse prostate after i
116 s demonstrated decreased signal intensity on T1-weighted images; on T2-weighted images, 13 collection
119 han were those obtained on contrast-enhanced T1-weighted images (P =.013) but were not different from
120 1: P < .001 for 2D T1-weighted imaging vs 3D T1-weighted imaging, P < .001 for 2D T1-weighted imaging
121 2: P < .001 for 2D T1-weighted imaging vs 3D T1-weighted imaging, P < .001 for 2D T1-weighted imaging
122 1: P < .001 for 2D T1-weighted imaging vs 3D T1-weighted imaging, P = .006 for 2D T1-weighted imaging
123 2: P = .006 for 2D T1-weighted imaging vs 3D T1-weighted imaging, P = .006 for 2D T1-weighted imaging
124 g vs 3D T1-weighted imaging, P = .006 for 2D T1-weighted imaging + PDFS imaging vs 3D T1-weighted ima
125 g vs 3D T1-weighted imaging, P = .006 for 2D T1-weighted imaging + PDFS imaging vs 3D T1-weighted ima
126 g vs 3D T1-weighted imaging, P < .001 for 2D T1-weighted imaging + PDFS imaging vs 3D T1-weighted ima
127 g vs 3D T1-weighted imaging, P < .001 for 2D T1-weighted imaging + PDFS imaging vs 3D T1-weighted ima
128 teristic curve) was higher for whole-body 3D T1-weighted imaging (per-patient analysis; observer 1: P
129 n-echo T2-weighted imaging and gradient-echo T1-weighted imaging performed before and after administr
131 tissues was significantly altered after IRE (T1-weighted images: pre-IRE, 145.95 +/- 24.32; post-IRE,
132 The only difference was the specificity for T1-weighted images read alone (65.7%) and read with T2-w
133 pecificity, 65.7%) were nearly identical for T1-weighted images read alone or read with T2-weighted i
134 T1-weighted imaging than with whole-body 2D T1-weighted imaging regardless of the reference region (
135 of signal intensity increases on unenhanced T1-weighted images relative to reference tissues in the
139 ted images and kurtosis on contrast-enhanced T1-weighted images showed a significant difference betwe
141 ) and non-fat-saturated (NFS) fast spin-echo T1-weighted imaging (T1 method), FS and NFS T2-weighted
144 uroimaging (volumetric measures derived from T1-weighted images, task-based functional magnetic reson
145 s significantly higher for contrast-enhanced T1-weighted images than for T2-weighted (P <.001) or STI
146 traparenchymal tumors, may be better seen on T1-weighted images than on postcontrast fast FLAIR image
147 were significantly higher with whole-body 3D T1-weighted imaging than with whole-body 2D T1-weighted
149 e overlaid on coregistered three-dimensional T1-weighted images to visually assess regions of heterot
150 to assess white matter integrity in the CST, T1-weighted imaging to measure cross-sectional spinal co
151 ted or FLAIR imaging and gadolinium-enhanced T1-weighted imaging (to look for primary or metastatic t
153 volume generation from a patient-specific MR T1-weighted image using a groupwise patch-based approach
155 lesion analysis; observer 1: P < .001 for 2D T1-weighted imaging vs 3D T1-weighted imaging, P < .001
156 eighted imaging; observer 2: P < .001 for 2D T1-weighted imaging vs 3D T1-weighted imaging, P < .001
157 atient analysis; observer 1: P < .001 for 2D T1-weighted imaging vs 3D T1-weighted imaging, P = .006
158 eighted imaging; observer 2: P = .006 for 2D T1-weighted imaging vs 3D T1-weighted imaging, P = .006
159 n between dependent and nondependent lung on T1 weighted images was also compared after turning betwe
160 efore embolization, high signal intensity on T1-weighted images was predictive of a poor response (P
161 ion Increased signal intensity on unenhanced T1-weighted images was seen in the posterior thalamus, s
164 The threshold temperature of enhancement at T1-weighted imaging was verified by monitoring the signa
171 one and for MR cholangiopancreatography plus T1-weighted images were high on average (0.98, 0.97, and
173 T2-weighted and dynamic gadolinium-enhanced T1-weighted images were obtained before and 3 months aft
177 ratios (CNRs) on arterial wall postcontrast T1-weighted images were superior to those on images obta
178 d the number of hypointense brain lesions on T1-weighted images were the strongest MR imaging paramet
180 T2-weighted and contrast agent-enhanced T1-weighted imaging were used to gauge the extent of tis
181 atograms and MR cholangiopancreatograms plus T1-weighted images, were evaluated independently by thre
182 the signal intensity of background liver on T1-weighted images, which increases the conspicuity of f
184 seen on STIR and contrast material-enhanced T1-weighted images with a radiologic and/or pathologic m
186 intensity of the liver on contrast-enhanced T1-weighted images with fat suppression (L(20)) and mean
187 intensity of the spleen on contrast-enhanced T1-weighted images with fat suppression (S(20)) on 3D gr
188 fat suppression (S(20)) on 3D gradient-echo T1-weighted images with fat suppression obtained at 20 m
190 nd T2-weighted imaging and three-dimensional T1-weighted imaging with and without contrast material e
191 R examinations, performed at 1.5 T, included T1-weighted imaging with fat and water in phase and grad
192 showed some areas of enhancement better with T1-weighted imaging with MT saturation and other areas b
193 T2-weighted MR cholangiopancreatography and T1-weighted imaging yields higher diagnostic performance
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。